Helix BioPharma Corp.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| HBP.TO | CHRS | ATORX.ST | PYXS | MGNX | 6OP.F | |
|---|---|---|---|---|---|---|
| Market cap | 70.27M | 131.36M | 38.89M | 198.30M | 147.15M | 42.99M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -8.4 | -1.3 | -0.1 | -1.5 | -1.6 | — |
| Price/book | 4.8 | 2.2 | 0.3 | 9.2 | 3.4 | 1.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −54.68% | −42.95% | −99.41% | −58.06% | +61.81% | −67.91% |
| Today | 0.00% | +5.54% | +1.87% | +1.22% | −0.86% | −2.85% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All HBP.TO news ›Helix BioPharma Corp. reports Q3 results
Helix BioPharma Q3 results show a narrower EPS loss and stronger cash reserves year over year. - Helix BioPharma Corp. press release (HBP:CA): Q3 EPS lossof C$0.04, narrowing 55.6% Y/Y. - Cash reserves stood at C$804K as of July 31, 2026,…
Helix BioPharma (TSE:HBP) Hits New 1-Year Low – Time to Sell?
Posted by Danessa Lincoln on Oct 25th, 2026 Shares of Helix BioPharma Corp. (TSE:HBP – Get Free Report) reached a new 52-week low during trading on Friday. The stock traded as low as C$0.85 and last traded at C$0.85, with a volume of 3,634…
More from 1 other outlet
Early Warning Press Release Regarding The Disposition Of Common Shares Of Helix Biopharma Corp. By Jerzy Wilczewski
Vancouver, October 19, 2026 - TheNewswire – Mr. Jerzy Wilczewski announces the disposition of 800,000 common shares (“Common Shares”) in the capital of Helix Biopharma Corp. (“Helix” or the “Corporation”) (TSX: HBP) at a price of C$1.30…
Helix BioPharma (TSE:HBP) Stock Crosses Below 50-Day Moving Average – Should You Sell?
Posted by Tristan Rich on Oct 14th, 2026 Helix BioPharma Corp. (TSE:HBP – Get Free Report)’s share price passed below its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of C$1.50 and traded as…
LB Pharmaceuticals (NASDAQ:LBRX) Stock Price Down 5.4% on Analyst Downgrade
Posted by Sarita Garza on Oct 5th, 2026 Read Our Latest Research Report on LB Pharmaceuticals The stock has a market capitalization of $1.13 billion and a P/E ratio of -10.17. The stock has a 50 day moving average price of $44.16 and a…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com3
- defenseworld.net1
- seekingalpha.com1
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.